You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)

✉ Email this page to a colleague

« Back to Dashboard

BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)

Docket	⤷ Sign Up	Date Filed	2015-07-31
Court	District Court, D. New Jersey	Date Terminated	2022-02-14
Cause	35:145 Patent Infringement	Assigned To	Kevin McNulty
Jury Demand	None	Referred To	Edward S. Kiel
Patents	8,022,082; 8,822,438
Link to Docket	External link to docket

Small Molecule Drugs cited in BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2016-03-08	176	Motion for Miscellaneous Relief	Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 by BTG INTERNATIONAL LIMITED, JANSSEN BIOTECH… 31 July 2015 2:15-cv-05909 830 Patent None District Court, D. New Jersey	External link to document
2016-03-08	179	Certificate of Service	Hearing And Correct Inventorship of U.S. Patent No. 8,822,438, 178 MOTION to Seal ECF No. 177 (MILLER,… 31 July 2015 2:15-cv-05909 830 Patent None District Court, D. New Jersey	External link to document
2016-03-21	185	Response in Opposition to Motion	Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 (Attachments: # 1 Declaration of Bryan D… 31 July 2015 2:15-cv-05909 830 Patent None District Court, D. New Jersey	External link to document
2016-03-28	187	Reply Brief to Opposition to Motion	Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 (Attachments: # 1 Certificate of Service… 31 July 2015 2:15-cv-05909 830 Patent None District Court, D. New Jersey	External link to document
2016-11-10	239	Opinion	Tablets (“ZYTIGA®”): United States Patent Nos. 8,822,438 (the “438 patent” …abbreviated as follows: • ‘438 patent = Copy of U.S. Patent No. 8,822,438, Exhibit 1 to the Declaration…partes review (“IPR”) of the ‘438 patent, the Patent Office’s Patent Trial and Appeal Board (“PTAB”) construed… 2 BTG owns the ‘213 patent and Janssen Oncology owns the ‘438 patent. The Janssen plaintiffs are…seeking to add patent infringement claims against certain of the Defendants as to U.S. Patent No. 8,236,946	External link to document
2016-12-15	255	Order	Janssen's motion to Correct Inventorship of U.S. Patent No. 8,822,438 35 U.S.C. Sec. 256 at the Post Office Courthouse… 31 July 2015 2:15-cv-05909 830 Patent None District Court, D. New Jersey	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.